Gianna Hoffman-Luca

Description

Gianna Hoffman-Luca, Ph.D., of Perceptive Xontogeny Venture Funds

Investor Profile

Gianna Hoffman-Luca has made 1 investments, with 0 in the past 12 months and 0% as lead.

Stage Focus

Series B (100%)

Country Focus

United States (100%)

Industry Focus

Biopharma
Biotechnology
Clinical Trials

FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Gianna Hoffman-Luca frequently co-invest with?

UCOP

North America, California, United States, Oakland

Co-Investments: 1

Blue Owl

North America, New York, United States, New York

Co-Investments: 1

Bristol-Myers Squibb

North America, New York, United States, New York

Co-Investments: 1

Goldman Sachs

North America, New York, United States, New York

Co-Investments: 1

UC Investments

North America, California, United States, Oakland

Co-Investments: 1

Moore Strategic Ventures

North America, New York, United States, New York

Co-Investments: 1

Avidity Partners

North America, Texas, United States, Dallas

Co-Investments: 1

RA Capital Management

North America, Massachusetts, United States, Boston

Co-Investments: 1

Deep Track Capital

North America, Connecticut, United States, Greenwich

Co-Investments: 1

Perceptive Advisors

North America, New York, United States, New York

Co-Investments: 1

What are some of recent deals done by Gianna Hoffman-Luca?

TORL BioTherapeutics

Culver City, California, United States

TORL BioTherapeutics is a clinical-stage biopharmaceutical business.

BiopharmaBiotechnologyClinical Trials

Series BApr 10, 2024

Amount Raised: $158,000,000

Gianna Hoffman-Luca

Description

Investor Profile

Stage Focus

Country Focus

Industry Focus

Frequently Asked Questions

Who does Gianna Hoffman-Luca frequently co-invest with?

What are some of recent deals done by Gianna Hoffman-Luca?

Ready to Raise Capital?

Pages

Free tools